34 Atopic Dermatitis Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting Atopic Dermatitis Studies in Bethesda

NCT02769975Recruiting

Evaluation of Children With Endocrine and Metabolic-Related Conditions

Background: Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might be caused by changes in genes. Genes con...

Bethesda, MD15,000 participantsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

View Study Details

NCT06732414Recruiting

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Background: Allergic or sinus diseases can affect the skin, sinuses, airways, and other parts of the body. Examples include pollen and environmental allergies, food allergies, asthma, and eczema. To ...

Bethesda, MD10,000 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT00250159Recruiting

Natural History Study of Patients With Excess Androgen

This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much androgen and describe pro...

Bethesda, MD3,000 participantsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

View Study Details

NCT03331380Recruiting

Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System

Background: Researchers are testing version of a system known as a magnetic resonance imagining (MRI) scanner that uses strong magnetic fields, radio waves and the like to create images of the organs...

Bethesda, MD2,950 participantsNational Heart, Lung, and Blood Institute (NHLBI)

View Study Details

NCT03000244Recruiting

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Background: People who have had an allogeneic hematopoietic stem cell transplant (HCT), cellular therapy (CT), or gene therapy (GT) have bone marrow or an immune system that is damaged. They get stem...

Bethesda, MD2,000 participantsNational Cancer Institute (NCI)

View Study Details

NCT05656365Recruiting

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

Background: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) is the most common periodic fever syndrome of childhood. Symptoms can include swelling of the glands in the...

Bethesda, MD1,500 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT03374215Recruiting

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

Background: The adrenal gland makes the hormone aldosterone. This helps regulate blood pressure. An adrenal gland tumor that makes too much aldosterone can cause high blood pressure and low potassium...

Bethesda, MD1,150 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT00605878Recruiting

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

This study will examine microbes (e.g., bacteria, fungi, viruses) that live on human skin and how microbes contribute to health and disease. It will analyze healthy human skin and how the these microo...

Bethesda, MD530 participantsNational Human Genome Research Institute (NHGRI)

View Study Details

NCT02379429Recruiting

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

Background: Urothelial cancer is cancer of the bladder, ureter, and urethra. Researchers want to better understand what changes in a person s cells and genes cause this cancer to form. This may help ...

Bethesda, MD500 participantsNational Cancer Institute (NCI)

View Study Details

NCT05592626Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent administered intravenously in participants with ad...

Bethesda, MD365 participantsMarengo Therapeutics, Inc.

View Study Details

NCT04915183Recruiting

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Background: Cisplatin is used to treat head and neck cancer. People who take this drug are at risk for hearing loss. Atorvastatin is a drug used to treat high cholesterol. It might reduce the risk of...

Bethesda, MD224 participantsNational Institute on Deafness and Other Communication Disorders (NIDCD)

View Study Details

NCT07498140Recruiting

Procedural Framing and Epidural Steroid Injection Outcomes

Back pain is the leading cause of disability and military medical boards across the globe. Epidural steroid injections (ESI) are the most commonly performed pain procedure in the world. There is stro...

Bethesda, MD210 participantsNorthwestern University

View Study Details

NCT04020510Recruiting

Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

OnabotulinumtoxinA is an effective treatment for both idiopathic and neurogenic overactive bladder and was FDA approved for this indication in 2013. The standard technique for injecting onabotulinumto...

Bethesda, MD184 participantsWalter Reed National Military Medical Center

View Study Details

NCT05270213Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

RBS2418 (investigational product) is a specific immune modulator, working through ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1), designed to lead to anti-tumor immunity by increasing endo...

Bethesda, MD164 participantsRiboscience, LLC.

View Study Details

NCT06729151Recruiting

Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome

Interstitial cystitis/bladder pain syndrome (IC/BPS) is estimated to affect 3.3 to 7.9 million women aged 18 years and older in the United States. The American Urological Association (AUA) defines IC/...

Bethesda, MD159 participantsWalter Reed National Military Medical Center

View Study Details

NCT05221021Recruiting

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

A single site, double-blinded, randomized controlled trial for postmenopausal women with urinary frequency, urgency, nocturia with or without urgency urinary incontinence symptoms. Patient's will be r...

Bethesda, MD152 participantsWalter Reed National Military Medical Center

View Study Details

NCT01631617Recruiting

Effects of Treatments on Atopic Dermatitis

Background: \- Atopic dermatitis, or eczema, is a chronic skin disorder. Patients sometimes have infections with S. aureus bacteria. Researchers want to study how eczema treatments affect the number ...

Bethesda, MD130 participantsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

View Study Details

NCT06096857Recruiting

Cardamom and Topical Roseomonas in Atopic Dermatitis

Background: Atopic dermatitis (AD), also called eczema, is a chronic skin condition. AD can make skin dry and itchy, and sometimes it can lead to serious health problems, such as asthma, food allergi...

Bethesda, MD120 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT03907475Recruiting

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

This phase II trial studies the side effects of durvalumab when given together with chemotherapy in treating patients with solid tumors that have spread to other places in the body (advanced). Immunot...

Bethesda, MD115 participantsNational Cancer Institute (NCI)

View Study Details

NCT05665361Recruiting

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Background: Kidney cancer is the 12th leading cause of cancer-related death in the United States. Some kidney tumors do not respond well to current treatments. Better treatments are needed. Objectiv...

Bethesda, MD100 participantsNational Cancer Institute (NCI)

View Study Details

NCT06223542Recruiting

Studying TAK-243 in Patients With Advanced Cancer

This phase I trial studies the side effects and best dose of ubiquitin-activating enzyme (UAE) inhibitor TAK-243 (TAK-243) in treating patients with a solid tumor that may have spread from where it fi...

Bethesda, MD95 participantsNational Cancer Institute (NCI)

View Study Details

NCT05521698Recruiting

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

This phase I trial evaluates the effects of bicalutamide, compared to no study drug (NSD), on epidermal growth factor receptor (EGFR) protein expression in patients with non-muscle invasive bladder ca...

Bethesda, MD80 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06247267Recruiting

The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population

It has been known that both estrogen and testosterone are the major sex steroids regulating bone metabolism and other physiological changes in both male and female, respectively. In postmenopausal wom...

Bethesda, MD75 participantsWalter Reed National Military Medical Center

View Study Details

NCT06041503Recruiting

Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Background: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. It can be hard to study treatments for the...

Bethesda, MD68 participantsNational Cancer Institute (NCI)

View Study Details

NCT06161532Recruiting

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Background: Rare tumors of the genitourinary (GU) tract can appear in the kidney, bladder, ureters, and penis. Rare tumors are difficult to study because there are not enough people to conduct large ...

Bethesda, MD60 participantsNational Cancer Institute (NCI)

View Study Details

NCT06257693Recruiting

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy....

Bethesda, MD56 participantsAlessa Therapeutics Inc.

View Study Details

NCT06228066Recruiting

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

Background: Small cell carcinoma of the bladder (SCCB) and other high-grade neuroendocrine tumors (HGNET) of the urinary tract are rare but aggressive cancers. Average survival for people diagnosed w...

Bethesda, MD45 participantsNational Cancer Institute (NCI)

View Study Details

NCT04550494Recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

This phase II trial studies if talazoparib works in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and has...

Bethesda, MD36 participantsNational Cancer Institute (NCI)

View Study Details

NCT05691517Recruiting

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

This phase I trial studies how well CBX-12 works in treating patients with solid tumors that have spread from where they first started (primary site) to started to nearby tissue, lymph nodes, or dista...

Bethesda, MD35 participantsNational Cancer Institute (NCI)

View Study Details

NCT06487481Recruiting

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Background: Adrenocortical carcinoma (ACC) is a rare cancer of the adrenal glands. ACC often returns after tumors are removed with surgery. Less than 35% of people with ACC survive 5 years after diag...

Bethesda, MD32 participantsNational Cancer Institute (NCI)

View Study Details

NCT06066138Recruiting

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that...

Bethesda, MD30 participantsNational Cancer Institute (NCI)

View Study Details

NCT05777603Recruiting

Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer

Background: Non-small cell lung cancer (NSCLC) can be hard to treat and is often fatal. People with NSCLC commonly have changes in the bacteria that populate their lungs. These bacterial changes may ...

Bethesda, MD23 participantsNational Cancer Institute (NCI)

View Study Details

NCT01212055Recruiting

Apheresis of Patients With Immunodeficiency

Background: \- Gene therapy is being investigated as a possible treatment for individuals with immunodeficiency diseases or other conditions that make it difficult to fight off infection. Gene therap...

Bethesda, MD7 participantsNational Cancer Institute (NCI)

View Study Details

NCT06204874Recruiting

New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome

Many women suffer from bladder pain syndrome (BPS). There are many treatments, but there is no one universally effective option. The goal of this clinical trial is to explore the use of electrical ene...

Bethesda, MD5 participantsWalter Reed National Military Medical Center

View Study Details

About Atopic Dermatitis Clinical Trials in Bethesda

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 34 atopic dermatitis clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 39,200 participants. Research is being sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI) and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Bethesda — FAQ

Are there atopic dermatitis clinical trials in Bethesda?

Yes, there are 34 atopic dermatitis clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 34 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 13, 2026 from ClinicalTrials.gov